Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Yates

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Nature|May 6, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicityGabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, et al.
Nature Communications|September 29, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy targetCong Fu, Robert Saddawi-Konefka, Jordan M Chinai, et al.
The New Phytologist|July 25, 2023
Expression quantitative trait loci mapping identified PtrXB38 as a key hub gene in adventitious root development in PopulusTao Yao, Jin Zhang, Timothy B Yates, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosisJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Nature Genetics|June 9, 2026
Inflammatory cytokines induce new cancer dependenciesCollins K Cheruiyot, Sarah Y Kim, Juan Dubrot, et al.
JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.
Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Science (New York, N.Y.)|July 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, et al.
Science (New York, N.Y.)|April 9, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunityJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Nature|May 6, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicityGabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, et al.
Nature Communications|September 29, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy targetCong Fu, Robert Saddawi-Konefka, Jordan M Chinai, et al.
The New Phytologist|July 25, 2023
Expression quantitative trait loci mapping identified PtrXB38 as a key hub gene in adventitious root development in PopulusTao Yao, Jin Zhang, Timothy B Yates, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosisJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Nature Genetics|June 9, 2026
Inflammatory cytokines induce new cancer dependenciesCollins K Cheruiyot, Sarah Y Kim, Juan Dubrot, et al.
JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.
Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Science (New York, N.Y.)|July 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, et al.
Science (New York, N.Y.)|April 9, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunityJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.
Pageof 17